SCHEMBL9983647

SCHEMBL9983647

CCOc1ccc(N2CCC(CNC=O)CC2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
MAPT P10636 5/20 0.50
KMT2A Q03164 5/20 0.45
ALOX15 P16050 2/20 0.45
HSD17B10 Q99714 1/20 0.45
MEN1 O00255 3/20 0.45
KDM4E B2RXH2 1/20 0.45
APP P05067 1/20 0.45
GAA P10253 1/20 0.45
ALOX12 P18054 1/20 0.45
MAPK1 P28482 1/20 0.45
SNCA P37840 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
NPC1 O15118 2/20 0.43
TP53 P04637 1/20 0.43
RAB9A P51151 1/20 0.43
BACE1 P56817 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ACACB O00763 5/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9983649 0.83 MAPT (0.51) ALDH1A1MAPTKMT2AALOX15HSD17B10
SCHEMBL9983648 0.77 MAPT (0.51) ALDH1A1MAPTKMT2AALOX15HSD17B10
SCHEMBL9984934 0.76 CKS1B (0.56) ALDH1A1MAPTKMT2AALOX15HSD17B10
SCHEMBL27363642 0.74 MAPT (0.65) ALDH1A1MAPTKMT2AALOX15HSD17B10
SCHEMBL28323351 0.73 MAPT (0.55) ALDH1A1MAPTKMT2AALOX15HSD17B10
SCHEMBL16769748 0.72 MAPT (0.52) ALDH1A1MAPTKMT2AALOX15HSD17B10
SCHEMBL4724848 0.71 MAPT (0.69) ALDH1A1MAPTKMT2AALOX15HSD17B10
SCHEMBL24654387 0.71 MAPT (0.49) ALDH1A1MAPTKMT2AALOX15HSD17B10
SCHEMBL16648554 0.70 MAPT (0.67) ALDH1A1MAPTKMT2AKDM4EGAA
SCHEMBL4720351 0.70 MAPT (0.68) ALDH1A1MAPTKMT2AALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096524-B2 Anthelmintic agents and their use INTERVET INTERNATIONAL B.V. (NL) 2015-08-04 US disclosed
EP-2408742-B1 ANTHELMINTIC AGENTS AND THEIR USE INTERVET INT BV (NL) 2014-09-03 EP disclosed
US-20110319393-A1 ANTHELMINTIC AGENTS AND THEIR USE INTERVET INTERNATIONAL B.V. (NL) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319393-A1 ANTHELMINTIC AGENTS AND THEIR USE ACHE, ABCB11, MPO ALDH1A1 864/4885MAPT 1648/4885KMT2A 1866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.